Skip to main content
Premium Trial:

Request an Annual Quote

Rockefeller Researcher Lands NIH Early Independence Award

NEW YORK (GenomeWeb News) – A Rockefeller University researcher plans to use a $1.3 million grant from the National Institutes of Health to develop a novel method for applying high-throughput sequencing to the study of human immune system function.

Brad Rosenberg, a biomedical fellow at Rockefeller, was one of 14 investigators chosen by the NIH Office of the Director to receive a total of $25.9 million under its Early Independence award program.

Funded through the NIH Common Fund, the program seeks to encourage young scientists with "outstanding creativity, intellectual maturity, and leadership skills" to conduct independent research projects.

"NIH is identifying those exceptional students that have the intellect, innovation, drive, and maturity to flourish independently without the need for traditional post-doctoral training," NIH Director Francis Collins said in a statement from NIH today.

In his research at Rockefeller, Rosenberg has already used high-throughput sequencing to study RNA editing and to discover targets for an enzyme that edits RNA, and now he wants to use sequencing to gain a better knowledge of molecular events in the immune system.

"As the technology becomes more advanced and less expensive, I see a huge untapped potential in high-throughput sequencing," Rosenberg said in a statement from Rockefeller today.

"I'm interested in developing tools that go beyond standard genome and transcriptome sequencing. We can apply the technology in ways that not only determine genetic sequences but also provide information about biological function," he added.

Specifically, he plans to study the complex populations of T and B cells in the immune system, and the receptors with which they engage their targets. He will use high-throughput sequencing to analyze receptor sequences in immune cells that are involved in recognition of potential threats and to study other related immune system functions.

"The early phases will involve technology development, and the ultimate goal is to transition the work to look at human responses — autoimmune disease and vaccine development, for example," Rosenberg said.

Rosenberg earned his PhD at Rockefeller in 2010 and over the past two years has been completing the clinical component of his MD at Weill-Cornell Medical College.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.